Updated on 21 October 2026
Metabolomics expertise for AI-driven predictive biomarker development
Project Manager at FUNDACIÓN MEDINA
Granada, Spain
About
Fundación MEDINA (Spain) is seeking to join a consortium preparing a proposal for HORIZON-HLTH-2027-02-TOOL-01-two-stage.
MEDINA offers expertise in targeted and untargeted metabolomics, advanced mass spectrometry, and biomarker discovery and validation. We aim to contribute to the identification of molecular signatures associated with disease progression and treatment response, supporting their integration with clinical and multi-omics data through AI methodologies.
We are looking for consortium coordinators, clinical partners and AI/bioinformatics experts interested in developing and validating predictive biomarkers for chronic non-communicable diseases.
Topic
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
Mercedes Gallardo
Project Manager at FUNDACIÓN MEDINA
Granada, Spain
Project cooperation
Fundación MEDINA –Natural product-based drug discovery expertise for novel small molecule antivirals
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Mercedes Gallardo
Project Manager at FUNDACIÓN MEDINA
Granada, Spain
Project cooperation
Research-use IAS image and genomic data integration partner for predictive biomarker consortia
- Partner seeks Consortium/Coordinator
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
daisuke kubota
Founder and CEO at Life Analytics Co., Ltd.
Yokohama, Japan